StockData
Ernexa Therapeutics Inc. logo

Ernexa Therapeutics Inc. (ERNA) income statement

ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.62−0.01 (-0.61%)

Close on Nov 18, 2026Market cap $2.64MP/E –Yield –

See a number that looks wrong?